Evidence map›Paper›PMID 32404946›Full record

ReviewMolecular psychiatry2021

Cortical cellular diversity and development in schizophrenia.

Amanda J Price, Andrew E Jaffe, Daniel R Weinberger

Open access · greenAbstract readReview
In one paragraph

Review in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amanda J PriceLieber Institute for Brain Development, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-7352-3732
Andrew E JaffeLieber Institute for Brain Development, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6886-1454
Daniel R WeinbergerLieber Institute for Brain Development, Baltimore, MD, USA. drweinberger@libd.org.ORCID http://orcid.org/0000-0003-2409-2969
Johns Hopkins University · US

Funding

BSMN Reference Tissue Project (Lieber Institute for Brain Development) 1U01MH106893-01 - 1/3-Schizophrenia Genetics and Brain Somatic MosaicismU01MH106893 · NIMH · LIEBER INSTITUTE, INC. · PI WEINBERGER, DANIEL · 2015 to 2019
$3.9M
Functional methylomics approaches for schizophrenia in the frontal cortex and hippocampusR01MH112751 · NIMH · LIEBER INSTITUTE, INC. · PI HAN, SHIZHONG · 2017 to 2021
$3.4M
Decomposing cell type-specific marks in post-mortem human brain studiesR21MH105853 · NIMH · LIEBER INSTITUTE, INC. · PI JAFFE, ANDREW ELLIS, WEINBERGER, DANIEL · 2015 to 2016
$509k
NIMH NIH HHS R01 MH112751NIMH NIH HHS R21 MH105853NIMH NIH HHS U01 MH106893
6 · The paper itself

Abstract

While a definitive understanding of schizophrenia etiology is far from current reality, an increasing body of evidence implicates perturbations in early development that alter the trajectory of brain maturation in this disorder, leading to abnormal function in early childhood and adulthood. This atypical development likely arises from an interaction of many brain cell types that follow distinct developmental paths. Because both cellular identity and development are governed by the transcriptome and epigenome, two levels of gene regulation that have the potential to reflect both genetic and environmental influences, mapping "omic" changes over development in diverse cells is a fruitful avenue for schizophrenia research. In this review, we provide a survey of human brain cellular composition and development, levels of genomic regulation that determine cellular identity and developmental trajectories, and what is known about how genomic regulation is dysregulated in specific cell types in schizophrenia. We also outline technical challenges and solutions to conducting cell type-specific functional genomic studies in human postmortem brain.

Indexed as

BrainGene Expression RegulationHumansSchizophreniaTranscriptome

Identifiers

PMID32404946
PMCPMC7666011
OpenAlexW3024450285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.